Related Experiment Video
Updated: Apr 30, 2026

Study of Protein-protein Interactions in Autophagy Research
Published on: September 9, 2017
Folliculin regulates ampk-dependent autophagy and metabolic stress survival
Elite Possik1, Zahra Jalali1, Yann Nouët1
1Goodman Cancer Research Center, McGill University, Montréal, Québec, Canada; Department of Biochemistry, McGill University, Montréal, Québec, Canada.
Abstract:
Dysregulation of AMPK signaling has been implicated in many human diseases, which emphasizes the importance of characterizing AMPK regulators. The tumor suppressor FLCN, responsible for the Birt-Hogg Dubé renal neoplasia syndrome (BHD), is an AMPK-binding partner but the genetic and functional links between FLCN and AMPK have not been established. Strikingly, the majority of naturally occurring FLCN mutations predisposing to BHD are predicted to produce truncated proteins unable to bind AMPK, pointing to the critical role of this interaction in the tumor suppression mechanism. Here, we demonstrate that FLCN is an evolutionarily conserved negative regulator of AMPK. Using Caenorhabditis elegans and mammalian cells, we show that loss of FLCN results in constitutive activation of AMPK which induces autophagy, inhibits apoptosis, improves cellular bioenergetics, and confers resistance to energy-depleting stresses including oxidative stress, heat, anoxia, and serum deprivation. We further show that AMPK activation conferred by FLCN loss is independent of the cellular energy state suggesting that FLCN controls the AMPK energy sensing ability. Together, our data suggest that FLCN is an evolutionarily conserved regulator of AMPK signaling that may act as a tumor suppressor by negatively regulating AMPK function.
Insights
Folliculin (FLCN) negatively regulates AMP-activated protein kinase (AMPK). Loss of FLCN causes constitutive AMPK activation, promoting cell survival and stress resistance, suggesting FLCN’s tumor suppressor role.
Area of Science:
- Cellular Biology
- Molecular Biology
- Genetics
Background:
- AMP-activated protein kinase (AMPK) signaling is crucial in human diseases.
- Dysregulated AMPK is linked to various pathologies, highlighting the need to understand its regulators.
- The tumor suppressor Folliculin (FLCN), linked to Birt-Hogg Dubé syndrome, interacts with AMPK, but their functional relationship is unclear.
Purpose of the Study:
- To investigate the genetic and functional links between Folliculin (FLCN) and AMP-activated protein kinase (AMPK).
- To determine the role of FLCN in regulating AMPK signaling and its implications in cellular processes and disease.
- To establish FLCN as a tumor suppressor by elucidating its mechanism involving AMPK.
Main Methods:
- Utilized Caenorhabditis elegans and mammalian cell models.
- Investigated the effects of FLCN loss on AMPK activity and downstream cellular responses.
- Assessed cellular bioenergetics, apoptosis, autophagy, and stress resistance under various conditions.
Main Results:
- Folliculin (FLCN) acts as an evolutionarily conserved negative regulator of AMPK.
- Loss of FLCN leads to constitutive AMPK activation, independent of cellular energy status.
- FLCN-deficient cells exhibit enhanced autophagy, inhibited apoptosis, improved bioenergetics, and increased resistance to diverse stresses.
Conclusions:
- FLCN is a critical regulator of AMPK energy sensing and signaling.
- FLCN may function as a tumor suppressor by inhibiting AMPK.
- Understanding the FLCN-AMPK axis provides insights into Birt-Hogg Dubé syndrome pathogenesis and potential therapeutic strategies.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cellular Injury V: Apoptosis and Autophagy
Regulation of the Unfolded Protein Response
cAMP-dependent Protein Kinase Pathways

